Implemented myeloma management with whole-body low-dose CT scan

a real life experience

Silvia Mangiacavalli, Sara Pezzatti, Fausto Rossini, Elisa Doni, Federica Cocito, Silvia Bolis, Alessandro Corso

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

A total of 318 consecutive myeloma patients underwent whole-body low-dose CT scan (WBLDCT) at baseline and during follow-up as a radiological assessment of lytic lesions in place of skeletal X-ray survey. After WBLDCT baseline assessment, 60% had bone involvement. The presence of lytic lesions represented the only met CRAB (hyperCalcaemia, Renal insufficiency, Anaemia, Bone lesions) criteria in 29% of patients. Patients presenting with extramedullary masses were 10%. Radiological progression was documented in 9% of the population with available follow-up. Additional pathological incidental findings were detected in 28 patients (14.5%), most located in the chest region (68%). In conclusion, our real-life data shows that WBLDCT scan represents a reliable imaging tool for decision-making process for multiple myeloma management in different disease phases, providing significant additional information on the presence of soft tissues plasmacytomas detection as well as the presence of pathological incidental findings.

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalLeukemia and Lymphoma
DOIs
Publication statusAccepted/In press - Jan 20 2016

Fingerprint

Life Change Events
Incidental Findings
Bone and Bones
Plasmacytoma
Hypercalcemia
Multiple Myeloma
Renal Insufficiency
Anemia
Decision Making
Thorax
X-Rays
Population

Keywords

  • Bone disease
  • multiple myeloma
  • whole body low-dose computed tomography

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Implemented myeloma management with whole-body low-dose CT scan : a real life experience. / Mangiacavalli, Silvia; Pezzatti, Sara; Rossini, Fausto; Doni, Elisa; Cocito, Federica; Bolis, Silvia; Corso, Alessandro.

In: Leukemia and Lymphoma, 20.01.2016, p. 1-7.

Research output: Contribution to journalArticle

Mangiacavalli, Silvia ; Pezzatti, Sara ; Rossini, Fausto ; Doni, Elisa ; Cocito, Federica ; Bolis, Silvia ; Corso, Alessandro. / Implemented myeloma management with whole-body low-dose CT scan : a real life experience. In: Leukemia and Lymphoma. 2016 ; pp. 1-7.
@article{1550ef87932c468b8e580d8ba62a642e,
title = "Implemented myeloma management with whole-body low-dose CT scan: a real life experience",
abstract = "A total of 318 consecutive myeloma patients underwent whole-body low-dose CT scan (WBLDCT) at baseline and during follow-up as a radiological assessment of lytic lesions in place of skeletal X-ray survey. After WBLDCT baseline assessment, 60{\%} had bone involvement. The presence of lytic lesions represented the only met CRAB (hyperCalcaemia, Renal insufficiency, Anaemia, Bone lesions) criteria in 29{\%} of patients. Patients presenting with extramedullary masses were 10{\%}. Radiological progression was documented in 9{\%} of the population with available follow-up. Additional pathological incidental findings were detected in 28 patients (14.5{\%}), most located in the chest region (68{\%}). In conclusion, our real-life data shows that WBLDCT scan represents a reliable imaging tool for decision-making process for multiple myeloma management in different disease phases, providing significant additional information on the presence of soft tissues plasmacytomas detection as well as the presence of pathological incidental findings.",
keywords = "Bone disease, multiple myeloma, whole body low-dose computed tomography",
author = "Silvia Mangiacavalli and Sara Pezzatti and Fausto Rossini and Elisa Doni and Federica Cocito and Silvia Bolis and Alessandro Corso",
year = "2016",
month = "1",
day = "20",
doi = "10.3109/10428194.2015.1129535",
language = "English",
pages = "1--7",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - Implemented myeloma management with whole-body low-dose CT scan

T2 - a real life experience

AU - Mangiacavalli, Silvia

AU - Pezzatti, Sara

AU - Rossini, Fausto

AU - Doni, Elisa

AU - Cocito, Federica

AU - Bolis, Silvia

AU - Corso, Alessandro

PY - 2016/1/20

Y1 - 2016/1/20

N2 - A total of 318 consecutive myeloma patients underwent whole-body low-dose CT scan (WBLDCT) at baseline and during follow-up as a radiological assessment of lytic lesions in place of skeletal X-ray survey. After WBLDCT baseline assessment, 60% had bone involvement. The presence of lytic lesions represented the only met CRAB (hyperCalcaemia, Renal insufficiency, Anaemia, Bone lesions) criteria in 29% of patients. Patients presenting with extramedullary masses were 10%. Radiological progression was documented in 9% of the population with available follow-up. Additional pathological incidental findings were detected in 28 patients (14.5%), most located in the chest region (68%). In conclusion, our real-life data shows that WBLDCT scan represents a reliable imaging tool for decision-making process for multiple myeloma management in different disease phases, providing significant additional information on the presence of soft tissues plasmacytomas detection as well as the presence of pathological incidental findings.

AB - A total of 318 consecutive myeloma patients underwent whole-body low-dose CT scan (WBLDCT) at baseline and during follow-up as a radiological assessment of lytic lesions in place of skeletal X-ray survey. After WBLDCT baseline assessment, 60% had bone involvement. The presence of lytic lesions represented the only met CRAB (hyperCalcaemia, Renal insufficiency, Anaemia, Bone lesions) criteria in 29% of patients. Patients presenting with extramedullary masses were 10%. Radiological progression was documented in 9% of the population with available follow-up. Additional pathological incidental findings were detected in 28 patients (14.5%), most located in the chest region (68%). In conclusion, our real-life data shows that WBLDCT scan represents a reliable imaging tool for decision-making process for multiple myeloma management in different disease phases, providing significant additional information on the presence of soft tissues plasmacytomas detection as well as the presence of pathological incidental findings.

KW - Bone disease

KW - multiple myeloma

KW - whole body low-dose computed tomography

UR - http://www.scopus.com/inward/record.url?scp=84955099600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955099600&partnerID=8YFLogxK

U2 - 10.3109/10428194.2015.1129535

DO - 10.3109/10428194.2015.1129535

M3 - Article

SP - 1

EP - 7

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

ER -